As of Oct 09
| +0.27 / +1.44%|
The 3 analysts offering 12-month price forecasts for Depomed Inc have a median target of 32.00, with a high estimate of 33.00 and a low estimate of 21.00. The median estimate represents a +68.42% increase from the last price of 19.00.
The current consensus among 4 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.